Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial

Lawlor, Brian; Segurado, Ricardo; Kennelly, Sean; Rikkert, Marcel G. M. Olde; Howard, Robert; Pasquier, Florence; Borjesson-Hanson, Anne; Tsolaki, Magda; Lucca, Ugo; Molloyid, D. William; Coen, Robert; Riepe, Matthias W.; Kalman, Janos; Kenny, Rose Anne; Cregg, Fiona; O'Dwyer, Sarah; Walsh, Cathal; Adams, Jessica; Banzi, Rita; Breuilh, Laetitia; Daly, Leslie; Hendrix, Suzanne; Aisen, Paul; Gaynor, Siobhan; Sheikhi, Ali; Taekema, Diana G.; Verhey, Frans R.; Nemni, Raffaello; Nobili, Flavio; Franceschi, Massimo; Frisoni, Giovanni; Zanetti, Orazio; Konsta, Anastasia; Anastasios, Orologas; Nenopoulou, Styliani; Tsolaki-Tagaraki, Fani; Pakaski, Magdolna; Dereeper, Olivier; de la Sayette, Vincent; Senechal, Olivier; Lavenu, Isabelle; Devendeville, Agnes; Calais, Gauthier; Crawford, Fiona; Mullan, Michael; NILVAD Study Grp

Erstveröffentlichung

2018

Metadata only
Search for full text

Wissenschaftlicher Artikel

Authors

Lawlor, Brian

Segurado, Ricardo

Kennelly, Sean

Rikkert, Marcel G. M. Olde

Howard, Robert

et al.

Institutions

Bezirkskrankenhaus Günzburg

Published in

PLoS Medicine ; 15 (2018), 9. - Art.-Nr. e1002660. - ISSN 1549-1676

Link to publication

https://dx.doi.org/10.1371/journal.pmed.1002660

Funding information

European Commission [279093]
UCLH NIHR Biomedical Research Centre, UK
Hauts-de-Freance Region, France
NILVAD / A European multicentre double-blind placebo-controlled phase III trial of nilvadIpine in mild to moderate Alzheimer’s disease / EC / FP7 / 279093

Dewey Decimal Group

DDC 610 / Medicine & health

Metadata

Show full item record